ClinicalTrials.gg
CompletedNCT03956238Updated Jul 10, 2023

Alcohol Myopia, Objectification, and Sexual Assault

An interventional study of Alcohol intoxication and Objectification in Alcoholic Intoxication, sponsored by University of Nebraska Lincoln. Completed at 1 site in United States. Open to participants aged 21 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-07-10.

Sponsored by University of Nebraska Lincoln · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
359
Allocation
Randomized
Ages
21 Years to 30 Years
Sex
All
01

Study summary

The present project integrates previous research on factors associated with alcohol-involved sexual assault, with research on how intoxication alters attention and social perceptions in ways that increase the risk of sexual aggression and victimization. Specifically, this project examines whether alcohol intoxication on the part of a male perpetrator impairs attentional capacity and leads to a narrowing of the perceptual field causing a dehumanizing perspective of women as sexual objects for men's pleasure rather than individuals with thoughts and feelings, thereby increasing the propensity for sexual aggression. The present research also examines whether women's responses to this sexual objectification from men interfere with risk perception in sexual situations, particularly when women are drinking, increasing the likelihood of sexual victimization.

Read the detailed description

These studies will provide a comprehensive test of our proposed model of alcohol-involved sexual assault that includes situation-specific mechanisms and key moderators of sexual violence. Specifically, hypotheses will be tested in the context of two carefully controlled laboratory studies. In Study 1, laboratory alcohol administration procedures will be used to manipulate intoxication (vs. placebo control) in men. Impaired attention and objectification will then be measured multi-modally including behavioral, self-report, and implicit measures. Finally, sexual aggression will be measured with a laboratory-based analogue of sexual assault. Study 2 will include women and follow the same alcohol administration procedures as Study 1. Additionally, mirroring men's objectification, objectifying gazes (vs. eye gazes) will also be manipulated. Impaired attention, self-objectification, and decreased sexual risk perceptions will then be assessed. Prior the laboratory visit, all participants will complete a battery of questionnaires to assess key moderators including a history of sexual assault perpetration and victimization, prior sexual objectification and self-objectification, as well as alcohol-related sex expectances and rape myth acceptance. The overall model will be analyzed within a conditional process model framework.

02

Conditions studied

  • Alcoholic Intoxication

Keywords

  • Alcohol intoxication
  • Alcohol use
  • Drinking
  • Sexual assault
  • Sexual violence
  • Aggression
  • Attention
  • Victimization
  • Public health
03

In context

Alcoholic Intoxication

76 studies on the registry are indexed under Alcoholic Intoxication; 17 are open to participants now.

This study's enrollment of 359 is above the median of 135 across 62 interventional studies indexed under Alcoholic Intoxication.

Browse Alcoholic Intoxication studies →

Lead sponsor

University of Nebraska Lincoln is the lead sponsor of 29 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
21 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 21-30 years of age
  • at least social drinkers
  • single
  • men attracted to women, women attracted to men

Exclusion criteria

Exclusion Criteria:

  • current/past alcohol dependence (as assessed by a score of 8 or higher on the Alcohol Dependence Scale), alcohol-related treatment, or hospitalization due to alcohol use
  • any past serious head injuries (as indicated by HELPS Brain Injury Screening Tool)
  • serious psychological symptoms (defined as past psychotic, paranoid, or bipolar disorders, or current major depression)
  • abstinence from alcohol use
  • a condition or medication use in which alcohol consumption is medically
  • any legal restriction against drinking (e.g., as condition of probation or parole)
  • presence of a positive breath alcohol concentration (BAC) upon arrival to the laboratory
  • if the participant is less than six feet tall and weighs over 250 pounds or is over six feet tall and weighs over 300 pounds
  • if a female participant is pregnant
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
359 participants (actual)

Study arms

  • Experimental
    Males and Alcohol Intoxication

    Men assigned to alcohol intoxication arm (target BAC .08%)

    Behavioral: Alcohol intoxication

  • Placebo comparator
    Males and Placebo Control

    Men assigned to placebo control arm

    Behavioral: Alcohol intoxication

  • Experimental
    Females and Alcohol Intoxication and Objectifying Gazes

    Women assigned to alcohol intoxication arm (target BAC .08%) and objectifying gazes arm

    Behavioral: Alcohol intoxication · Behavioral: Objectification

  • Experimental
    Females and Alcohol Intoxication and Eye Gazes

    Women assigned to alcohol intoxication arm (target BAC .08%) and eye gazes arm

    Behavioral: Alcohol intoxication · Behavioral: Objectification

  • Experimental
    Females and Placebo Control and Objectifying Gazes

    Women assigned to placebo control arm and objectifying gazes arm

    Behavioral: Alcohol intoxication · Behavioral: Objectification

  • Placebo comparator
    Females and Placebo Control and Eye Gazes

    Women assigned to placebo control arm and eye gazes arm

    Behavioral: Alcohol intoxication · Behavioral: Objectification

Interventions

  • BehavioralAlcohol intoxication

    Men and women assigned to moderate alcohol dose condition (target BAC .08%) or placebo control condition with NIAAA approved alcohol administration procedures

  • BehavioralObjectification

    Women assigned to objectifying gazes condition or eye contact control condition

06

What researchers measure

Primary outcomes

  1. Laboratory analogue of sexual aggression

    After learning that a woman does not like sexual media, male participants choose to show her a sexually explicit video or control video (selection of the sexually explicit video indicates more sexual aggression)

    Time frame: 20 minutes post alcohol or placebo dosing

  2. Sexual assault vignette measure of risk perception

    Female participants read 18 vignettes describing a sexual interaction between a man and a woman that gets progressively riskier for sexual assault and indicate when they would leave the interaction (scores range from 1-18 and higher scores indicate worse risk perception)

    Time frame: 20 minutes post alcohol or placebo dosing

Secondary outcomes

  1. Eye-tracking measure of sexual objectification

    Male participants wear a portable eye tracker and discuss media preferences with a female confederate while dwell time on the female confederate's face and body is monitored (longer dwell times on the woman's body and shorter dwell times on the woman's face indicate more sexual objectification)

    Time frame: 2 minutes post alcohol or placebo dosing

  2. Eye-tracking measure of self-objectification

    Female participants wear a portable eye tracker and interact with a male confederate in front of a mirror while dwell time on the participant's body is monitored (longer dwell times on the participant's body indicates more self-objectification)

    Time frame: 2 minutes post alcohol or placebo dosing

  3. Object brief-implicit association task

    On a computer, male participants sort stimuli words representing the categories object (e.g., tool), human (e.g., person), women (e.g., female), and men (male). Participants must respond as quickly and accurately as possible to categorize the words on a computer screen to object, human, women, and men categories via a computer key press. Responding faster to object and woman words and slower to woman and human words indicates implicit objectification of women

    Time frame: 25 minutes post alcohol or placebo dosing

  4. Self-object brief-implicit association task

    On a computer, female participants sort stimuli words representing the categories object (e.g., tool), human (e.g., person), me (e.g., self), and others (them). Participants must respond as quickly and accurately as possible to categorize the words on a computer screen to object, human, me, and others categories via a computer key press. Responding faster to object and me words and slower to human and me words indicates implicit self-objectification.

    Time frame: 25 minutes post alcohol or placebo dosing

  5. Self-report state mindful attention awareness scale

    Male and female participants self-report how attentive they feel on a 0 to 6 point scale (averaged lower scores indicate more mindful attention awareness)

    Time frame: 30 minutes post alcohol or placebo dosing

  6. Self-report other-objectification questionnaire

    Male participants self-report how frequently they objectified the female confederate on a 1 to 6 point scale (averaged higher scores indicate more other-objectification)

    Time frame: 35 minutes post alcohol or placebo dosing

  7. Self-report self-objectification questionnaire

    Female participants self-report how important appearance related attributes (e.g., sex appeal) are important to their self-concept relative to non-appearance attributes (e.g., hobbies) on a 0 to 9 point scale. Appearance attributes and non-appearance attributes are separately summed and non-appearance attribute scores are subtracted from appearance attribute scores (higher scores indicate more self-objectification)

    Time frame: 35 minutes post alcohol or placebo dosing

  8. Saliva collection

    Female participants provide saliva samples to assess cortisol associated with stress responses

    Time frame: 5 minutes pre alcohol or placebo dosing, 5 minutes post alcohol dosing, and 20 minutes post alcohol or placebo dosing

07

Study locations

1 site
  • University of Nebraska-Lincoln
    Lincoln, Nebraska 68588, United States
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Yes — De-identified individual participant data may be shared with other researchers (e.g., posted to the Open Science Framework) to aid with reproducibility and replicability of science.

Supporting information: Study protocol, Statistical analysis plan, Analytic code

Time frame: De-identified data may be made available to interested researchers when papers based on that data are published in scientific journals.

Access criteria: Interested researchers will be required to have an Open Science Framework account.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2019 to primary completion in Dec 2022, 44 months.

Of 29 interventional studies with no phase under Alcoholic Intoxication, half reached primary completion within 40 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 58. This study's 44 months is close to that.

How these figures are worked out, and which studies are left out of them.

Registered
May 2, 2019
First posted
May 20, 2019
StartActual
Apr 22, 2019
Primary completionActual
Dec 31, 2022
CompletionActual
Dec 31, 2022
Last update
Jul 10, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 10, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03956238
Lead sponsor
University of Nebraska Lincoln
Responsible party
Sponsor
First posted
May 20, 2019
Start date
Apr 22, 2019
Primary completion
Dec 31, 2022
Completion
Dec 31, 2022
Last update
Jul 10, 2023

Study contacts

Sarah Gervais, PhD
principal investigator · University of Nebraska Lincoln

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion